Literature DB >> 35236108

Hydrodynamic Impact on Blood: From Left Ventricular Assist Devices to Artificial Hearts.

Angelo Nascimbene1, Jing-Fei Dong2,3.   

Abstract

Entities:  

Keywords:  Editorials; artificial heart transplantation; heart failure; hemolysis; left ventricular assist device; thrombosis; von Willebrand factor

Mesh：

Substances：

Year:  2022        PMID： 35236108      PMCID： PMC8957568          DOI： 10.1161/ATVBAHA.122.317517

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  37 in total

1.  Long-term use of a left ventricular assist device for end-stage heart failure.

Authors:  E A Rose; A C Gelijns; A J Moskowitz; D F Heitjan; L W Stevenson; W Dembitsky; J W Long; D D Ascheim; A R Tierney; R G Levitan; J T Watson; P Meier; N S Ronan; P A Shapiro; R M Lazar; L W Miller; L Gupta; O H Frazier; P Desvigne-Nickens; M C Oz; V L Poirier
Journal:  N Engl J Med       Date:  2001-11-15       Impact factor: 91.245

2.  Formation of platelet strings and microthrombi in the presence of ADAMTS-13 inhibitor does not require P-selectin or beta3 integrin.

Authors:  A K Chauhan; T Goerge; S W Schneider; D D Wagner
Journal:  J Thromb Haemost       Date:  2006-12-13       Impact factor: 5.824

3.  A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report.

Authors:  Mandeep R Mehra; Nir Uriel; Yoshifumi Naka; Joseph C Cleveland; Melana Yuzefpolskaya; Christopher T Salerno; Mary N Walsh; Carmelo A Milano; Chetan B Patel; Steven W Hutchins; John Ransom; Gregory A Ewald; Akinobu Itoh; Nirav Y Raval; Scott C Silvestry; Rebecca Cogswell; Ranjit John; Arvind Bhimaraj; Brian A Bruckner; Brian D Lowes; John Y Um; Valluvan Jeevanandam; Gabriel Sayer; Abeel A Mangi; Ezequiel J Molina; Farooq Sheikh; Keith Aaronson; Francis D Pagani; William G Cotts; Antone J Tatooles; Ashok Babu; Don Chomsky; Jason N Katz; Paul B Tessmann; David Dean; Arun Krishnamoorthy; Joyce Chuang; Ia Topuria; Poornima Sood; Daniel J Goldstein
Journal:  N Engl J Med       Date:  2019-03-17       Impact factor: 91.245

4.  Immediate recovery of acquired von Willebrand syndrome after left ventricular assist device explantation: implications for heart transplantation.

Authors:  Mary E Davis; Nicholas A Haglund; Nicole M Tricarico; Anton Matafonov; David Gailani; Simon Maltais
Journal:  ASAIO J       Date:  2015 Jan-Feb       Impact factor: 2.872

5.  Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device.

Authors:  George V Letsou; Nyma Shah; Igor D Gregoric; Timothy J Myers; Reynolds Delgado; O H Frazier
Journal:  J Heart Lung Transplant       Date:  2005-01       Impact factor: 10.247

6.  Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device.

Authors:  Anna L Meyer; Doris Malehsa; Christoph Bara; Ulrich Budde; Mark S Slaughter; Axel Haverich; Martin Strueber
Journal:  Circ Heart Fail       Date:  2010-08-25       Impact factor: 8.790

7.  Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device.

Authors:  Francis D Pagani; Leslie W Miller; Stuart D Russell; Keith D Aaronson; Ranjit John; Andrew J Boyle; John V Conte; Roberta C Bogaev; Thomas E MacGillivray; Yoshifumi Naka; Donna Mancini; H Todd Massey; Leway Chen; Charles T Klodell; Juan M Aranda; Nader Moazami; Gregory A Ewald; David J Farrar; O Howard Frazier
Journal:  J Am Coll Cardiol       Date:  2009-07-21       Impact factor: 24.094

8.  Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation.

Authors:  Andrew J Boyle; Stuart D Russell; Jeffrey J Teuteberg; Mark S Slaughter; Nader Moazami; Francis D Pagani; O Howard Frazier; Gerald Heatley; David J Farrar; Ranjit John
Journal:  J Heart Lung Transplant       Date:  2009-09       Impact factor: 10.247

Review 9.  Acquired von Willebrand syndrome associated with left ventricular assist device.

Authors:  Angelo Nascimbene; Sriram Neelamegham; O H Frazier; Joel L Moake; Jing-Fei Dong
Journal:  Blood       Date:  2016-05-03       Impact factor: 22.113

10.  Time course of acquired von Willebrand disease associated with two types of continuous-flow left ventricular assist devices: HeartMate II and CircuLite Synergy Pocket Micro-pump.

Authors:  Motohiko Goda; Steven Jacobs; Filip Rega; Kathelijne Peerlinck; Marc Jacquemin; Walter Droogne; Johan Vanhaecke; Johan Van Cleemput; Klaartje Van den Bossche; Bart Meyns
Journal:  J Heart Lung Transplant       Date:  2013-05       Impact factor: 10.247
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.